Meanwhile, PL has been shown to effectively inhibit HMGB1 in different disease models, including cholestatic liver injury, hepatic ischemic re-injury, and sepsis (Zhang Z. et al., 2016; Zaki et al., 2018; Pan et al., 2022). Here, HMGB1 is linked to Sepsis.